These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 19698704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
    Avila J, Wandosell F, Hernández F.
    Expert Rev Neurother; 2010 May; 10(5):703-10. PubMed ID: 20420491
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V, Lanfranco M, Summa M, Porceddu PF, Ciampoli M, Margaroli N, Durando L, Garrone B, Ombrato R, Tongiani S, Reggiani A.
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [Abstract] [Full Text] [Related]

  • 6. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.
    Nakashima H, Ishihara T, Suguimoto P, Yokota O, Oshima E, Kugo A, Terada S, Hamamura T, Trojanowski JQ, Lee VM, Kuroda S.
    Acta Neuropathol; 2005 Dec; 110(6):547-56. PubMed ID: 16228182
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
    Shimamura K, Kitazawa H, Miyamoto Y, Kanesaka M, Nagumo A, Yoshimoto R, Aragane K, Morita N, Ohe T, Takahashi T, Nagase T, Sato N, Tokita S.
    J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
    [Abstract] [Full Text] [Related]

  • 14. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T, Yu JT, Zhu XC, Zhang QQ, Cao L, Wang HF, Tan MS, Gao Q, Qin H, Zhang YD, Tan L.
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy.
    Wong H, Belvin M, Herter S, Hoeflich KP, Murray LJ, Wong L, Choo EF.
    J Pharmacol Exp Ther; 2009 Apr; 329(1):360-7. PubMed ID: 19147858
    [Abstract] [Full Text] [Related]

  • 16. Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors.
    Cho GW, Noh MY, Kang BY, Ku IW, Park J, Hong YH, Kim MH, Kim SH.
    Assay Drug Dev Technol; 2011 Oct; 9(5):503-13. PubMed ID: 21561378
    [Abstract] [Full Text] [Related]

  • 17. Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation.
    Shim SB, Lim HJ, Chae KR, Kim CK, Hwang DY, Jee SW, Lee SH, Sin JS, Leem YH, Lee SH, Cho JS, Lee HH, Choi SY, Kim YK.
    Neuroscience; 2007 May 11; 146(2):730-40. PubMed ID: 17337327
    [Abstract] [Full Text] [Related]

  • 18. Coexpression of GSK-3beta corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau.
    Nuydens R, Van Den Kieboom G, Nolten C, Verhulst C, Van Osta P, Spittaels K, Van den Haute C, De Feyter E, Geerts H, Van Leuven F.
    Neurobiol Dis; 2002 Feb 11; 9(1):38-48. PubMed ID: 11848683
    [Abstract] [Full Text] [Related]

  • 19. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
    Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH.
    Am J Pathol; 2003 Sep 11; 163(3):1057-67. PubMed ID: 12937146
    [Abstract] [Full Text] [Related]

  • 20. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J.
    FEBS Lett; 2006 May 22; 580(12):2922-7. PubMed ID: 16529745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.